|
|
|
04.12.25 - 15:15
|
Eli Lilly Aktie: Abnehm-Pipeline sorgt für neue Fantasie (Aktiencheck)
|
|
|
Toronto (www.aktiencheck.de) - Eli Lilly-Aktienanalyse von BMO Capital Markets:
BMO Capital Markets habe das Kursziel für die Aktie von Eli Lilly and Company (ISIN: US5324571083, WKN: 858560, Ticker-Symbol: LLY, NYSE-Symbol: LLY) von 1.100 auf 1.200 USD angehoben und das "outperform"-Rating bestätigt. [mehr]...
|
|
|
04.12.25 - 11:24
|
FDA approves Eli Lilly′s Jaypirca in relapsed or refractory CLL/SLL (PBR)
|
|
|
This applies to patients previously treated with a covalent Bruton tyrosine kinase (BTK) inhibitor. The approval broadens Jaypirca's label to cover patients at an earlier stage of treatment
The post FDA approves Eli Lilly's Jaypirca in relapsed or refractory CLL/SLL appeared first on Pharmaceutical Business review....
|
|
|
|
|
|
|
|
|
|
|
|
|
03.12.25 - 16:48
|
GXP-Storage Appoints Former Eli Lilly Global Clinical Research Executive Chris Otto to Board of Directors (Business Wire)
|
|
|
Veteran brings over three decades of global clinical research experience to strengthen innovation and international expansion
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--GXP-Storage®, a life sciences leader in compliant, visible and scalable material management, announced today the appointment of Chris Otto as an Independent Board Member, effective November 12, 2025. With over three decades of global clinical research and development experience, Otto brings deep operational expertise from his career at Eli Lilly and Company, where he most recently served as Global Leader and Associate Vice President of Clinical Laboratory Sciences, including accountability for clinical imaging and connected devices.
Otto's appointment advances GXP-Storage's mission to simplify material management across the full clinical lifecycle. As decentralized and hybrid trials become the norm, the company's purpose-built facilities and GXP-Guardian® digital platform provide sponsors with complete visibility, validated enviro...
|
|
|
|
|
03.12.25 - 16:36
|
Eli Lilly Aktie: Kommt jetzt der nächste GLP-1-Blockbuster? (Aktiencheck)
|
|
|
Charlotte (www.aktiencheck.de) - Eli Lilly-Aktienanalyse der Bank of America (BofA):
Der BofA-Analyst Tim Anderson habe das "buy"-Rating für die Aktie von Eli Lilly and Company (ISIN: US5324571083, WKN: 858560, Ticker-Symbol: LLY, NYSE-Symbol: LLY) bestätigt und das Kursziel von 950 auf 1.286 USD angehoben. [mehr]...
|
|
|
03.12.25 - 14:06
|
Excelsior Sciences Raises $95 Million to Transform Small Molecule Discovery and Manufacturing with Novel Chemistry that Machines Can Do (Business Wire)
|
|
|
Deerfield Management, Khosla Ventures, and Sofinnova Partners co-lead Series A fundraise for Excelsior Sciences to accelerate drug discovery and clinical development while supporting pharma reshoring.
NEW YORK--(BUSINESS WIRE)--Excelsior Sciences, a company developing a new form of chemistry that machines can do and AI can use to enable closed-loop drug discovery, today announced it has raised $95 million to accelerate its mission to reinvent the process of discovering and manufacturing small molecules.
The financing includes a $70 million Series A, co-led by Deerfield Management, Khosla Ventures, and Sofinnova Partners, as well as a $25 million grant from New York's Empire State Development. Other participants include Cornucopian Capital, Eli Lilly and Company, Illinois Ventures, and the leading academic institution, MIT.
A Novel Approach for Small Molecule Science
Small molecules, the class of chemical matter primarily built from carbon-carbon bonds, perform countless essential functions in our lives: ...
|
|
|
|
|
02.12.25 - 17:18
|
Wall Street Bulls are Pounding the Table Over Amazon, Eli Lilly, and Apple (24/7 Wall St.)
|
|
|
After a rough pullback, the major indices are attempting to rebound higher.Helping, not only is Bitcoin starting to rebound, but so are down but not out tech stocks. Plus, markets are optimistic that the Federal Reserve will cut interest rates again next week. We also continue to see a significant number of upgrades from market ... Wall Street Bulls are Pounding the Table Over Amazon, Eli Lilly, and Apple
The post Wall Street Bulls are Pounding the Table Over Amazon, Eli Lilly, and Apple appeared first on 24/7 Wall St.....
|
|
|
|
|
|
|
|
|
|
|
|
|
01.12.25 - 16:18
|
Lilly Cuts Prices for Cash Buyers of Weight-Loss Drug Zepbound (Bloomberg)
|
|
|
Eli Lilly is cutting prices again for those who pay cash for introductory doses of the weight-loss drug Zepbound. The lowest dose vial will cost $299 a month, that would be a saving of about $50. It's part of the price war with rival Novo Nordisk. Bloomberg's Madison Muller reports. (Source: Bloomberg)...
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
